ArticleAmerican journal of respiratory and critical care medicine2018

Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.

Corina N D'Alessandro-Gabazza et al.PubMed ↗Publisher ↗

No numbers read from the abstract.